An Adult Spasticity Registry of OnabotulinumtoxinA Treatment

• Status: Completed
• Trial end date: 2017-10-09
• Target enrollment: 0
• Participant gender: All

Summary

This is a registry study in adults with spasticity to determine onabotulinumtoxinA use in clinical practice. Treatment will be administered in accordance with physician standard practice. All treatment decisions lie with the physician.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; incobotulinumtoxinA; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• Treatment with onabotulinumtoxinA according to the decision of the physician for spasticity

• Willingness to complete study questionnaires and answer study questions by phone or internet

Exclusion Criteria:

• Concurrent participation in a clinical trial for spasticity